In this line, systemic administration of AD-MSCs or EVs had different effects on eosinophil cell counts, levels of IL-4, IL-13, and eotaxin in lung tissue, CD3+CD4+ T cells in BALF, and lung mechanics. The gene discussed is CD4; the disease is Alzheimer disease.